Scabies Treatment Guidelines

Recommended Treatment Options

• The Centers for Disease Control and Prevention recommends permethrin 5% cream as the first-line topical treatment for uncomplicated scabies, applied to all areas of the body from the neck down and washed off after 8-14 hours 1
• The Centers for Disease Control and Prevention recommends oral ivermectin (200 μg/kg, repeated in 2 weeks) as the recommended oral medication for uncomplicated scabies 1
• Ivermectin should be taken with food to increase bioavailability and penetration into the epidermis, with no dosage adjustments required for patients with renal impairment 2
• Permethrin is particularly recommended for infants, young children, and pregnant/lactating women 1

Special Considerations

• The Centers for Disease Control and Prevention recommends combination therapy for crusted (Norwegian) scabies, including topical scabicide (5% permethrin cream) applied daily for 7 days, then twice weekly until discharge/cure, plus oral ivermectin 200 μg/kg on days 1, 2, 8, 9, and 15 3
• Lindane should be avoided in children <10 years, pregnant or lactating women, and persons with extensive dermatitis due to risk of neurotoxicity and other adverse effects 1, 4, 3

Management of Contacts and Environment

• The Centers for Disease Control and Prevention recommends examining and treating all persons who have had sexual, close personal, or household contact with the patient within the preceding month 1
• Decontaminate bedding and clothing by machine washing/drying using hot cycle, dry cleaning, or removing from body contact for at least 72 hours 1

Follow-Up and Treatment Failure

• Rash and pruritus may persist for up to 2 weeks after successful treatment, and consider retreatment after 2 weeks if symptoms persist or live mites are observed 1
• Reasons for persistent symptoms include treatment failure, reinfection from untreated contacts or fomites, and cross-reactivity with other household mites 1, 3

Treatment Pitfalls to Avoid

• Failure to treat all close contacts simultaneously, inadequate application of topical treatments, and using lindane after bathing or in contraindicated populations can lead to treatment failure 1
• Not repeating ivermectin dose after 2 weeks and expecting immediate resolution of symptoms can also lead to treatment failure 1

Scabies Treatment and Prevention

Recommended Treatment Options

• The Centers for Disease Control and Prevention recommends using lindane (1%) or sulfur (6%) ointment as alternative treatments for scabies, with specific application and washing instructions, and precautions for certain populations 5
• The Centers for Disease Control and Prevention suggests that fumigation of living areas is unnecessary for scabies treatment and prevention 5

Management of Contacts and Environment

• The Centers for Disease Control and Prevention advises against using lindane incorrectly, such as after bathing or in contraindicated populations, including children under 10 years, pregnant or lactating women, and persons with extensive dermatitis due to risk of neurotoxicity 5

Management of Scabies Patient Return to General Ward After Permethrin Treatment

Special Considerations

• For immunocompromised patients, closer monitoring may be necessary as they are at increased risk for treatment failure, according to the MMWR Recommendations and Reports 6

Treatment of Crusted Scabies

Introduction to Crusted Scabies

• Crusted scabies (Norwegian scabies) is an aggressive infestation that occurs in immunodeficient, debilitated, or malnourished persons and is far more contagious than typical scabies, with the skin harboring thousands to millions of mites 7, 8
• The Centers for Disease Control and Prevention recommends that crusted scabies be treated with aggressive combination therapy 7, 8

Treatment Approach

• The American Academy of Dermatology and the Centers for Disease Control and Prevention suggest that no controlled therapeutic studies exist for crusted scabies, and substantial treatment failure occurs with single-dose topical scabicide or oral ivermectin alone 8
• The Centers for Disease Control and Prevention recommends taking oral ivermectin with food to increase bioavailability and epidermal penetration 7
• The multiple-dose schedule of oral ivermectin addresses ivermectin's limited ovicidal activity and the massive mite burden 7

Treatment Pitfalls

• The Centers for Disease Control and Prevention advises against using single-application permethrin as recommended for ordinary scabies, as this will fail in crusted scabies 8
• The Centers for Disease Control and Prevention recommends not skipping the oral ivermectin component, as topical therapy alone is insufficient given the mite burden and thick crusts 8
• The Centers for Disease Control and Prevention suggests avoiding lindane in this population, as crusted scabies patients are often immunocompromised or debilitated, making them vulnerable to lindane neurotoxicity 7

Scabies Treatment Guidelines

Retreatment Criteria

• The Centers for Disease Control and Prevention recommends retreatment after 1 week for symptomatic patients, though others only recommend it if live mites are observed 9
• Evaluation at 2 weeks post-treatment for persistent symptoms is necessary to determine if retreatment is needed, according to the MMWR Recommendations and Reports 9

Special Populations

• No specific guidelines from reputable sources like the American Academy of Dermatology or the CDC are provided in the article, however, the MMWR Recommendations and Reports suggests that symptomatic patients may require retreatment after 1 week 9

Use of Triamcinolone Cream with Scabies Treatment

Clinical Algorithm for Corticosteroid Use

• The American Academy of Dermatology recommends that triamcinolone or other topical corticosteroids should only be considered if pruritus persists beyond the expected 2-week post-treatment period and only after confirming that live mites are not present, with limited application to affected areas only to minimize risks of atrophy, pigmentary changes, and telangiectasias 10
• The American Academy of Dermatology notes that applying corticosteroids during the permethrin or ivermectin treatment phase can suppress the inflammatory response that helps identify active infestation and may theoretically allow mites to proliferate more easily, and therefore should not be used during active treatment, but rather after treatment has been completed, with triamcinolone or other topical corticosteroids considered for post-scabetic eczema 10

Simultaneous Treatment of All Household Contacts Is Essential to Prevent Scabies Treatment Failure

Incubation Period and Asymptomatic Transmission

• The CDC notes that scabies has a 4‑6 week incubation period during which infected persons remain contagious despite being asymptomatic, making untreated contacts the most common cause of treatment failure. (Expert consensus) 11

Rationale for Treating All Contacts at the Same Time

• Treating only the symptomatic index case permits asymptomatic household members to reinfect the patient within days to weeks after successful therapy. (Expert consensus) [11][12]
• After successful treatment, the index patient can become a source of reinfestation for others, creating a transmission cycle that may persist for months. (Expert consensus) [11][13]
• Persistent symptoms after apparent cure are frequently due to reinfection from untreated family members or contaminated fomites. (Expert consensus) [11][12]

High‑Risk Populations

• Elderly or immunocompromised individuals are prone to crusted scabies, which may harbor thousands to millions of mites and dramatically increase transmission risk. (Expert consensus) 11

Environmental Decontamination Requirements

• The CDC recommends machine‑washing and drying all bedding, clothing, and towels on hot cycles (or dry‑cleaning them) as a necessary adjunct to contact treatment. (Expert consensus) 11
• Fumigation of living areas is unnecessary because mites cannot survive off‑host beyond 48 hours at room temperature. (Expert consensus) 11

Common Pitfalls to Avoid

• Retreatment within two weeks based solely on ongoing itching is discouraged; post‑treatment pruritus is expected and does not indicate treatment failure. (Expert consensus) 11

CDC‑Guided Management of Scabies

First‑Line Pharmacologic Recommendations

• Permethrin 5 % cream is the preferred topical agent for pregnant and lactating individuals because ivermectin lacks sufficient safety data in these groups (CDC Recommendations, 2015) 14.
• Oral ivermectin (200 µg/kg) is contraindicated in children weighing <15 kg or younger than 10 years due to risk of central‑nervous‑system toxicity (CDC Recommendations, 2015) 14.

Management of Crusted (Norwegian) Scabies

• Specialist consultation is mandatory for patients with crusted scabies (CDC Recommendations, 2015) 14.
• Crusted scabies occurs most frequently in immunocompromised hosts (e.g., HIV infection, severe debilitation, malnutrition) and requires close monitoring (CDC Recommendations, 2015) 14.

Treatment of Pregnant and Lactating Persons

• Permethrin 5 % cream remains the first‑choice therapy for scabies in pregnancy and lactation (CDC Recommendations, 2015) 14.
• Ivermectin is classified as “low risk” based on limited human data, but permethrin is still recommended as the primary option (CDC Recommendations, 2015) 14.

Contact and Environmental Control

• All household members, sexual partners, and close contacts within the preceding month must receive simultaneous scabies treatment, even if asymptomatic (CDC Recommendations, 2015) 14.
• Environmental decontamination should include machine‑washing and drying of bedding, clothing, and towels on hot cycles or dry‑cleaning (CDC Recommendations, 2015) 14.

Post‑Treatment Follow‑Up

• Pruritus and rash may persist for up to 2 weeks after successful therapy due to allergic dermatitis; this does not indicate treatment failure (CDC Recommendations, 2015) 15.
• Retreatment should be considered only after 2 weeks if symptoms continue or live mites are identified (CDC Recommendations, 2015) 14.
• When initial therapy fails, switching to an alternative regimen (e.g., permethrin ↔ ivermectin) is advised (CDC Recommendations, 2015) 14.

Causes of Treatment Failure

• Re‑infection from untreated contacts or contaminated fomites is a common cause of therapeutic failure (CDC Recommendations, 2015) [15][14].
• Incomplete decontamination of bedding and clothing contributes to persistent infestation (CDC Recommendations, 2015) 15.

Institutional Outbreak Management

• Control of an outbreak requires simultaneous treatment of the entire at‑risk population (CDC Recommendations, 2015) 14.
• Mass oral ivermectin administration is recommended for nursing homes, hospitals, and residential facilities to facilitate delivery (CDC Recommendations, 2015) 14.
• Outbreak response should be coordinated with a scabies specialist (CDC Recommendations, 2015) 14.

Agents to Avoid

• Lindane must never be used in children younger than 10 years, pregnant or lactating persons, or individuals with extensive dermatitis because of its high neurotoxicity and risk of aplastic anemia (CDC Recommendations, 2015) 14.